MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
ARCA biopharma ROA Ratio 2011-2026 | ABIO
Annual ROA Ratio ARCA biopharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.14 | -14.1 | -23.04 | -35.18 | -19.31 | -64.22 | -116.21 | -149.4 | -66.84 | -28.92 | -60.06 | -40.62 | -134.5 | -82.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -14.1 | -149.4 | -61.15 |
Quarterly ROA Ratio ARCA biopharma
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25.3 | -26.27 | -85.12 | -78.11 | -80.98 | -77.71 | -15.59 | -13.31 | -13.16 | -14.72 | -17.53 | -20.74 | -28.35 | -24.58 | -31.97 | -31.49 | -31.32 | -27.44 | -30.2 | -34.44 | -38.64 | -48.23 | -52.43 | -56.63 | -64.08 | -73.88 | -81.34 | -88.79 | -100.92 | -113.43 | -241.15 | -368.86 | -401.69 | -432.6 | -349.84 | -200.3 | -229.22 | -191.37 | -153.53 | -86.76 | -146.82 | -177.96 | -209.1 | -180.18 | -220.8 | -201.36 | -181.91 | -121.85 | -256.35 | -350.23 | -444.1 | -403.49 | -485.98 | -433.99 | -381.99 | -247.49 | -82.5 | -82.5 | -82.5 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -13.16 | -485.98 | -148.7 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M |  Canada |
 |
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
-37.44 | $ 2.8 | -3.69 % | $ 158 M |  China |
 |
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
-1.44 | $ 80.89 | -1.35 % | $ 1.56 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
4.45 | $ 341.41 | -0.45 % | $ 183 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-34.19 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M |  France |
 |
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
-10.92 | $ 2.68 | 3.88 % | $ 16.8 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.23 | -1.01 % | $ 7.77 B |  Australia |
 |
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-140.01 | - | 3.16 % | $ 1.9 M | USA |
 |
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | USA |
 |
Aptose Biosciences
APTO
|
-251.11 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | USA |
 |
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | USA |
 |
Biogen
BIIB
|
5.82 | $ 177.21 | 0.61 % | $ 25.8 B | USA |
 |
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
-34.13 | $ 28.43 | -2.94 % | $ 2.34 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-35.36 | $ 224.26 | 0.14 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
-164.92 | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
-62.67 | - | -11.76 % | $ 5.79 M | USA |
 |
BioNTech SE
BNTX
|
65.02 | $ 115.04 | -1.49 % | $ 27.2 B | Germany |
 |
Burford Capital Limited
BUR
|
5.51 | $ 9.65 | - | $ 1.52 B | Britain |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.12 | $ 68.78 | -0.5 % | $ 9.2 B | USA |
 |
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-123.72 | - | -10.17 % | $ 12.2 K | USA |
 |
CASI Pharmaceuticals
CASI
|
-26.5 | $ 1.01 | 1.6 % | $ 137 M | USA |
 |
Catalyst Biosciences
CBIO
|
-73.35 | $ 9.79 | -3.55 % | $ 644 M | USA |
 |
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-104.83 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-40.29 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
-43.36 | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 4.0 | -3.61 % | $ 8.7 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
-2.11 | $ 14.0 | -0.78 % | $ 4.33 B | USA |
 |
AIkido Pharma
AIKI
|
-31.2 | - | 1.93 % | $ 17.4 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-249.92 | - | -74.18 % | $ 955 K | USA |
 |
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | USA |
 |
Cerus Corporation
CERS
|
-10.41 | $ 2.28 | -1.94 % | $ 421 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | USA |
 |
Baudax Bio
BXRX
|
-586.07 | - | 0.59 % | $ 63 K | USA |